MyFinsight
Home
Blog
About
Contact
Download
Download image
Diagnostics-Operating Segments
$2,762,100K
(5.04%↑ Y/Y)
Biopharma Laboratory
Services-Operating Segments
$780,600K
(8.22%↑ Y/Y)
Revenues
$3,537,600K
(5.75%↑ Y/Y)
Intersegment Elimination
-$5,100K
(12.07%↑ Y/Y)
Gross profit
$1,013,800K
(6.94%↑ Y/Y)
Cost of revenues
$2,523,800K
(5.29%↑ Y/Y)
Operating income
$380,800K
(16.81%↑ Y/Y)
Investment income
$12,200K
(87.69%↑ Y/Y)
Selling, general, and
administrative expenses
$551,000K
(0.92%↑ Y/Y)
Amortization of intangibles
and other assets
$75,600K
(8.62%↑ Y/Y)
Restructuring and other
charges
$6,400K
(0.00%↑ Y/Y)
Earnings from operations
before income taxes
$319,700K
(16.17%↑ Y/Y)
Interest expense
$55,100K
(-1.61%↓ Y/Y)
Other, net
-$13,100K
(-1210.00%↓ Y/Y)
Equity method loss, net
-$5,100K
(-1600.00%↓ Y/Y)
Net earnings
$278,000K
(30.52%↑ Y/Y)
Provision for income taxes
$41,700K
(-32.96%↓ Y/Y)
Net earnings
attributable to labcorp...
$277,800K
(30.55%↑ Y/Y)
Less net earnings
attributable to the...
$200K
(0.00%↑ Y/Y)
Back
Back
Income Statement
Labcorp_Logo-svg
LABCORP HOLDINGS INC. (LH)
Labcorp_Logo-svg
LABCORP HOLDINGS INC. (LH)
source: myfinsight.com